IUBio Biosequences .. Software .. Molbio soft .. Network News .. FTP

[Computational-biology] Structure-Based Drug Design

Jim Prudhomme via comp-bio%40net.bio.net (by jprudhomme from healthtech.com)
Wed Feb 4 13:03:03 EST 2009

***Registration is Now Open for Cambridge Healthtech Institute’s

Structure-Based Drug Design: Sophisticated Approaches to Drug Discovery
June 4-5, 2009
Royal Sonesta Hotel, Cambridge, Massachusetts


Topics of discussion include:

-          Target Structure-Guided Drug Discovery

-          Feeding SBDD with Biochemical and Biophysical Information

-          Ligand-Based Predictions Applied to Drug Design

-          SBDD and Computational Chemistry Methods: A Marriage of

-           SBDD of Pharmacological Chaperons

Distinguished Faculty:

Alex Aronov, Ph.D., Vertex Pharmaceuticals, Inc.


Xavier Barril, Ph.D. , ICREA Research Universitat de Barcelona


Alex Burgin, Ph.D., deCODE Biostructures


Miles Congreve, Ph.D., Heptares Therapeutics Ltd.


José Duca, Ph.D., Schering Plough Research Institute


Stefan Geschwindner, Ph.D., AstraZeneca R&D Mölndal


Ajay N. Jain, Ph.D., University of California, San Francisco


Paul Labute, Ph.D., Computing Group (CCG)


Dr. Richard J. Law, Evotec AG


Brian B. Masek, Ph.D., Tripos International


Mark Murcko, Ph.D., Vertex Pharmaceuticals, Inc.


Sander Nabuurs, Ph.D., Radboud University Nijmegen


Enrico O. Purisima, Ph.D., National Research Council of Canada


Dagmar Ringe, Ph.D., Brandeis University


Suo-Bao Rong, Ph.D., Pfizer Global R&D


Tomi Sawyer, Ph.D., AILERON Therapeutics; Editor-in-Chief, Chemical Biology
& Drug Design


Andrew D. Scott, Ph.D., Pfizer Global Research and Development


Suresh Singh, Ph.D., Vitae Pharmaceuticals


Raymond C. Stevens, Scripps Research Institute


Gergely Toth, Ph.D., Elan Pharmaceuticals


Marcel Verdonk, Ph.D., Astex Therapeutics, Ltd.


Markus Wagener, Ph.D., Schering-Plough Research Institute


W. Patrick Walters, Ph.D., Vertex Pharmaceuticals, Inc.


Plus! Pre-Conference Workshop, Wednesday, June 3

Designing Kinase Inhibitors*


Topics Discussed:

- Challenges of Crystal Structures

- X-Ray Crystallography

- Target Immobilized NMR Screening

*Separate registration is required.


Arrive early to attend...

Protein Kinase Targets

June 1-3



Interested in Sponsorships and Exhibit Opportunities?


Katelin Fitzgerald

Manager, Business Development

Tel: 781-972-5458

E-mail: kfitzgerald from healthtech.com


Special Pricing is Available to Attend Both the Structure-Based Drug Design
and Protein Kinase Conferences.

Learn more and register at www.healthtech.com/SBD/overview.aspx

Otherwise, call CHI at 781-972-5400.

More information about the Comp-bio mailing list

Send comments to us at biosci-help [At] net.bio.net